Skip to main content
. 2019 Aug 27;10:1879. doi: 10.3389/fimmu.2019.01879

Table 8.

ROC curve analysis for patients with malignant diseases.

Parameter Cutoff within 80% specificity P-value AUC 95% confidence interval
CD19+CD21low % 11.49 0.04 0.581 0.529–0.632
CD56+ × 103 cells/ml >360 0.062 0.576 0.522–0.629
IgM mg/dl >168 0.62 0.522 0.466–0.578
CD19+CD27+IgD× 103 cells/ml ≤ 7.76 0.0002 0.643 0.581–0.702
Monocytes × 103 cells/ml >600 0.0045 0.624 0.570–0.676
Ratio CD19+CD21low/CD19+CD27+ >1.32 <0.0001 0.671 0.609–0.729

AUC, area under the curve; ROC, receiver operating characteristic.